Adobe
ADBE
Lennar Corp
LEN
Petroleo Brasileiro SA Petrobras
PBR
D.R. Horton
DHI
Oracle
ORCL
US Stock MarketDetailed Quotes
RVNC Revance Therapeutics
- 3.075
- -0.005-0.16%
Trading Dec 26 13:36 ET
321.00MMarket Cap-1.60P/E (TTM)
3.080High3.070Low329.95KVolume3.070Open3.080Pre Close1.01MTurnover0.34%Turnover RatioLossP/E (Static)104.39MShares9.74552wk High-1.97P/B294.99MFloat Cap2.30052wk Low--Dividend TTM95.93MShs Float42.410Historical High--Div YieldTTM0.33%Amplitude2.300Historical Low3.075Avg Price1Lot Size
Revance Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 19.37%-41.09M | 22.96%-41.13M | 5.12%-65.94M | -11.90%-216.58M | -41.58%-42.73M | 11.94%-50.96M | -20.71%-53.38M | -13.43%-69.5M | 12.63%-193.55M | 32.34%-30.18M |
| Net income from continuing operations | 73.00%-38.12M | 44.33%-37.47M | 11.11%-53.15M | 9.10%-323.99M | 61.84%-55.7M | -66.69%-141.18M | -9.58%-67.32M | 7.07%-59.79M | -26.70%-356.42M | -131.31%-145.95M |
| Depreciation and amortization | -41.08%1.25M | -59.53%1.43M | -70.07%1.98M | -65.02%13.69M | -92.28%1.42M | -75.81%2.13M | -46.57%3.53M | 23.10%6.62M | 97.18%39.15M | 239.14%18.38M |
| Other non cash items | 190.12%1.97M | 158.92%1.82M | -11.30%738K | -2.15%3.04M | 76.27%832K | -55.07%678K | 11.62%701K | 66.07%832K | 165.81%3.11M | 396.84%472K |
| Change In working capital | 36.40%-8.98M | -143.93%-10.85M | 18.79%-23.14M | -6,698.80%-43.88M | -82.53%3.18M | -1,217.26%-14.12M | -654.61%-4.45M | -65.19%-28.49M | 113.93%665K | 833.80%18.18M |
| -Change in receivables | -45.44%-12.18M | -271.32%-6.2M | 45.22%-2.21M | -104.48%-16.34M | -674.37%-2.26M | -36.29%-8.37M | -49.24%-1.67M | -259.22%-4.03M | -426.00%-7.99M | 123.31%394K |
| -Change in inventory | 45.85%-3.47M | -17.37%-4.71M | 72.34%-2.11M | -148.17%-14.91M | 428.09%3.16M | -103.04%-6.42M | -36.36%-4.01M | -1,418.69%-7.64M | -40.44%-6.01M | 1,473.68%598K |
| -Change in prepaid assets | 108.20%731K | 23.59%-1.38M | 109.49%123K | -288.79%-6.79M | 15.03%5.23M | -829.41%-8.91M | -816.75%-1.81M | -720.10%-1.3M | 305.37%3.6M | 165.92%4.54M |
| -Change in payables and accrued expense | -187.06%-8.2M | 89.84%4.52M | -2.76%-18.72M | -81.47%1.88M | -47.85%8.29M | 115.00%9.42M | -55.36%2.38M | -17.51%-18.22M | 102.28%10.12M | 318.95%15.9M |
| -Change in other current assets | 110.73%1.75M | -2,503.69%-18.89M | 103.11%711K | -386.75%-35.5M | -22.65%2.87M | -398.46%-16.33M | -98.51%786K | 66.97%-22.83M | 49.27%-7.29M | -59.08%3.71M |
| -Change in other current liabilities | -113.27%-1.92M | 2,819.75%19.42M | -104.01%-958K | 407.87%32.07M | -19.38%-5.58M | 277.80%14.45M | 98.64%-714K | -66.64%23.91M | -54.18%6.31M | -294.76%-4.67M |
| -Change in other working capital | 601.03%14.3M | -715.87%-3.61M | -98.08%31K | -322.18%-4.29M | -272.16%-8.53M | -72.67%2.04M | 263.23%586K | 156.03%1.62M | 218.33%1.93M | -93.58%-2.29M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 19.37%-41.09M | 22.96%-41.13M | 5.12%-65.94M | -11.90%-216.58M | -41.58%-42.73M | 11.94%-50.96M | -20.71%-53.38M | -13.43%-69.5M | 12.63%-193.55M | 32.34%-30.18M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -54.85%23.29M | 82.57%-6.89M | -133.27%-31.71M | 179.06%109.74M | -94.21%2.37M | 143.55%51.59M | 62.66%-39.53M | 113.87%95.32M | -367.88%-138.8M | 48.19%40.96M |
| Net PPE purchase and sale | 98.65%-61K | 1,024.81%2.99M | -494.71%-5.17M | -114.52%-6.89M | -38.12%-1.78M | -349.40%-4.5M | -50.37%266K | 40.25%-870K | 69.06%-3.21M | 70.44%-1.29M |
| Net investment purchase and sale | -54.23%27.22M | 88.39%-4.62M | -127.59%-26.54M | 204.94%121.51M | -87.23%5.65M | 154.30%59.47M | 60.39%-39.8M | 92.43%96.19M | -899.03%-115.79M | 38.22%44.23M |
| Net other investing changes | ---3.87M | ---- | ---- | 75.34%-4.88M | 24.24%-1.5M | ---- | ---- | ---- | -157.14%-19.8M | ---1.98M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -54.85%23.29M | 82.57%-6.89M | -133.27%-31.71M | 179.06%109.74M | -94.21%2.37M | 143.55%51.59M | 62.66%-39.53M | 113.87%95.32M | -367.88%-138.8M | 48.19%40.96M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -116.25%-6.09M | -103.50%-3.41M | 2,743.12%92.83M | -58.83%136.57M | 73.61%-1.63M | -82.28%37.46M | 360.53%97.47M | -96.90%3.27M | 1,010.50%331.69M | -1,624.20%-6.17M |
| Net issuance payments of debt | -113.68%-5.72M | 39.25%-3.9M | -70.03%-4.23M | -65.35%30.16M | 55.03%-2.74M | 1,390.15%41.8M | -264.38%-6.41M | -102.53%-2.49M | --87.05M | ---6.1M |
| Net common stock issuance | --0 | --0 | --97.63M | -59.61%100.18M | --0 | --0 | 339.07%100.18M | --0 | 1,042.61%248.01M | --0 |
| Proceeds from stock option exercised by employees | -91.38%5K | -87.59%557K | -99.79%20K | 217.20%15.29M | -42.18%1.26M | -88.67%58K | 119.19%4.49M | 11,901.27%9.48M | -71.12%4.82M | 31.46%2.18M |
| Net other financing activities | 91.50%-374K | 90.48%-75K | 84.16%-591K | -10.64%-9.07M | 93.44%-148K | -111.19%-4.4M | 59.38%-788K | -94.98%-3.73M | 3.89%-8.19M | -79.98%-2.26M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -116.25%-6.09M | -103.50%-3.41M | 2,743.12%92.83M | -58.83%136.57M | 73.61%-1.63M | -82.28%37.46M | 360.53%97.47M | -96.90%3.27M | 1,010.50%331.69M | -1,624.20%-6.17M |
| Net cash flow | ||||||||||
| Beginning cash position | -40.47%88.5M | -2.89%139.93M | 25.85%144.75M | -0.56%115.02M | 69.13%186.74M | 97.31%148.66M | -29.46%144.1M | -0.56%115.02M | -65.68%115.67M | -16.50%110.41M |
| Current changes in cash | -162.71%-23.88M | -1,228.62%-51.43M | -116.57%-4.82M | 4,660.12%29.73M | -1,011.83%-41.99M | 8.58%38.08M | 103.53%4.56M | -67.18%29.08M | 99.71%-652K | 127.80%4.61M |
| End cash Position | -65.40%64.61M | -40.47%88.5M | -2.89%139.93M | 25.85%144.75M | 25.85%144.75M | 69.13%186.74M | 97.31%148.66M | -29.46%144.1M | -0.56%115.02M | -0.56%115.02M |
| Free cash flow | 25.81%-41.15M | 28.20%-38.14M | -1.06%-71.11M | -13.57%-223.46M | -41.44%-44.51M | 5.79%-55.47M | -21.58%-53.12M | -12.19%-70.37M | 15.16%-196.76M | 35.73%-31.47M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.